SOL GEL (Germany) Performance

4SG Stock  EUR 0.49  0.02  4.26%   
The entity has a beta of 0.78, which indicates possible diversification benefits within a given portfolio. As returns on the market increase, SOL GEL's returns are expected to increase less than the market. However, during the bear market, the loss of holding SOL GEL is expected to be smaller as well. At this point, SOL GEL TECHN has a negative expected return of -0.1%. Please make sure to validate SOL GEL's coefficient of variation, jensen alpha, and the relationship between the downside deviation and information ratio , to decide if SOL GEL TECHN performance from the past will be repeated at future time.

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days SOL GEL TECHN IS 10 has generated negative risk-adjusted returns adding no value to investors with long positions. Despite latest uncertain performance, the Stock's basic indicators remain stable and the current disturbance on Wall Street may also be a sign of long-run gains for the company stockholders. ...more
  

SOL GEL Relative Risk vs. Return Landscape

If you would invest  56.00  in SOL GEL TECHN IS 10 on August 30, 2024 and sell it today you would lose (10.00) from holding SOL GEL TECHN IS 10 or give up 17.86% of portfolio value over 90 days. SOL GEL TECHN IS 10 is currently producing negative expected returns and takes up 6.4465% volatility of returns over 90 trading days. Put another way, 57% of traded stocks are less volatile than SOL, and 99% of all traded equity instruments are likely to generate higher returns over the next 90 trading days.
  Expected Return   
       Risk  
Assuming the 90 days horizon SOL GEL is expected to under-perform the market. In addition to that, the company is 8.35 times more volatile than its market benchmark. It trades about -0.02 of its total potential returns per unit of risk. The Dow Jones Industrial is currently generating roughly 0.15 per unit of volatility.

SOL GEL Market Risk Analysis

Today, many novice investors tend to focus exclusively on investment returns with little concern for SOL GEL's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as SOL GEL TECHN IS 10, and traders can use it to determine the average amount a SOL GEL's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.

Sharpe Ratio = -0.016

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative Returns4SG

Estimated Market Risk

 6.45
  actual daily
57
57% of assets are less volatile

Expected Return

 -0.1
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.02
  actual daily
0
Most of other assets perform better
Based on monthly moving average SOL GEL is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of SOL GEL by adding SOL GEL to a well-diversified portfolio.

SOL GEL Fundamentals Growth

SOL Stock prices reflect investors' perceptions of the future prospects and financial health of SOL GEL, and SOL GEL fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on SOL Stock performance.

About SOL GEL Performance

By analyzing SOL GEL's fundamental ratios, stakeholders can gain valuable insights into SOL GEL's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if SOL GEL has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if SOL GEL has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Sol-Gel Technologies Ltd., a clinical stage specialty pharmaceutical company, focuses on developing and commercializing topical dermatological drug products based on its proprietary microencapsulation delivery system in Israel. The company was incorporated in 1997 and is headquartered in Ness Ziona, Israel. SOL GEL operates under Biotechnology classification in Germany and is traded on Frankfurt Stock Exchange. It employs 65 people.

Things to note about SOL GEL TECHN performance evaluation

Checking the ongoing alerts about SOL GEL for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for SOL GEL TECHN help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
SOL GEL TECHN generated a negative expected return over the last 90 days
SOL GEL TECHN has high historical volatility and very poor performance
SOL GEL TECHN has some characteristics of a very speculative penny stock
The company reported the revenue of 24.59 M. Net Loss for the year was (27.21 M) with profit before overhead, payroll, taxes, and interest of 10.89 M.
SOL GEL TECHN IS 10 has accumulated about 38.88 M in cash with (27.03 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 1.69, which can makes it an attractive takeover target, given it will continue generating positive cash flow.
Roughly 74.0% of the company shares are owned by insiders or employees
Evaluating SOL GEL's performance can involve analyzing a variety of financial metrics and factors. Some of the key considerations to evaluate SOL GEL's stock performance include:
  • Analyzing SOL GEL's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
  • Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether SOL GEL's stock is overvalued or undervalued compared to its peers.
  • Examining SOL GEL's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
  • Evaluating SOL GEL's management team can have a significant impact on its success or failure. Reviewing the track record and experience of SOL GEL's management team can help you assess the Company's leadership.
  • Pay attention to analyst opinions and ratings of SOL GEL's stock. These opinions can provide insight into SOL GEL's potential for growth and whether the stock is currently undervalued or overvalued.
It's essential to remember that evaluating SOL GEL's stock performance is not an exact science, and many factors can impact SOL GEL's stock market price. Therefore, it's also important to diversify your portfolio and not rely solely on one company or stock for your investments.

Complementary Tools for SOL Stock analysis

When running SOL GEL's price analysis, check to measure SOL GEL's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy SOL GEL is operating at the current time. Most of SOL GEL's value examination focuses on studying past and present price action to predict the probability of SOL GEL's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move SOL GEL's price. Additionally, you may evaluate how the addition of SOL GEL to your portfolios can decrease your overall portfolio volatility.
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum
Balance Of Power
Check stock momentum by analyzing Balance Of Power indicator and other technical ratios
Odds Of Bankruptcy
Get analysis of equity chance of financial distress in the next 2 years
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Piotroski F Score
Get Piotroski F Score based on the binary analysis strategy of nine different fundamentals
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Portfolio Dashboard
Portfolio dashboard that provides centralized access to all your investments
Volatility Analysis
Get historical volatility and risk analysis based on latest market data